Methylphenidate-mediated motor control network enhancement in patients with traumatic brain injury. by Dorer, Charlie L et al.
 
 
1 
 
Methylphenidate-mediated motor control network enhancement in patients with 
traumatic brain injury 
Charlie L. Dorera, Anne E. Manktelowa; Judith Allansonb; Barbara J. Sahakianc; John D. 
Pickardd; Andrew Batemane, David K. Menona, Emmanuel A. Stamatakisa  
Author institutional affiliations:  
a) Division of Anaesthesia, University of Cambridge, School of Clinical Medicine, 
Addenbrooke’s Hospital, Cambridge, UK. 
b) Cambridge University Hospitals NHS Foundation, Cambridge, UK 
c) Department of Psychiatry, University of Cambridge, UK. 
d) Academic Neurosurgery Unit, University of Cambridge, UK. 
e) Oliver Zangwill Centre, Ely, UK. 
Corresponding author:  Dr Emmanuel A. Stamatakis, Division of Anaesthesia, University 
of Cambridge School of Clinical Medicine, Box 93, Addenbrooke’s Hospital, Hills Road, 
Cambridge, CB2 2QQ, UK            eas46@cam.ac.uk.  
 
 
 
 
2 
 
Abstract  
Primary Objective: To investigate functional improvement late (>6 months) after 
traumatic brain injury. To this end, we conducted a double-blind, placebo-controlled 
experimental medicine study to test the hypothesis that a widely used cognitive 
enhancer would benefit patients with traumatic brain injury (TBI). 
Research Design: We focused on motor control function using a sequential finger 
opposition fMRI paradigm in both patients and age-matched controls. 
Methods and Procedures: Patients’ fMRI and DTI scans were obtained after 
randomised administration of methylphenidate or placebo. Controls were scanned 
without intervention. To assess differences in motor speed, we compared reaction times 
from the baseline condition of a sustained attention task.  
Main Outcomes and Results: Patients’ reaction times correlated with wide-spread 
motor-related white matter abnormalities. Administration of methylphenidate resulted in 
faster reaction times in patients, which were not significantly different from those 
achieved by controls. This was also reflected in the fMRI findings in that patients on 
methylphenidate activated the left inferior frontal gyrus significantly more than when on 
placebo. Furthermore, stronger functional connections between pre/post-central cortices 
and cerebellum were noted for patients on methylphenidate.  
Conclusions: Our findings suggest that residual functionality in patients with TBI may be 
enhanced by a single dose of methylphenidate. 
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1. Introduction  
The motor control network (MCN) incorporates remote brain regions and involves short- 
and long-range interactions between cortical and subcortical areas. Movement involves 
the integration of information between the motor cortex including the premotor cortex 
and basal ganglia, cerebellum as well as the peripheral nervous system. Moreover, 
movement control entails a continuous loop from feedback to feed-forward involving 
both predictive and reactive processes. Lemon, 2008 [1], provides a comprehensive 
description of motor control as a process which results from operations involving the 
entire motor network.  
The motor cortex (including the premotor cortex) plans and controls the execution of 
voluntary motor functions and is considered to be the major source of motor control. 
Cerebellar-thalamo-cortical interactions are thought to have a role in computing the 
pattern of muscle activation necessary in order to produce smooth co-ordinated 
movement [2]. The cerebellum is thought to adapt movement by trial learning 
mechanisms, although what information is predicted or how the information is derived at 
the neural circuit level is still debated [3]. The cerebellum also interacts with vestibular 
and reticular nuclei to provide bilateral postural control [4]. Intact functionality of these 
systems provides the necessary means for efficient, goal directed movement and 
conversely impaired activation of these systems results in compromised movement [5]. 
Following traumatic brain injury (TBI), alteration in motor control function can result from 
several mechanisms of injury in the central nervous system (CNS) [6]. These 
mechanisms may include diffuse axonal injury, deep cerebral haemorrhage, focal 
 
 
4 
 
cortical contusion, transtentorial herniation and hypoxic-ischemic injury [7]. Our group 
previously examined MCN reorganisation in patients with TBI using a finger-thumb 
opposition paradigm with functional MRI (fMRI) [8]. On that occasion we reported fewer 
interhemispheric interactions in patients compared to controls as well as the total 
absence of anticorrelations between MCN regions, in contrast to healthy controls. 
Reduced functional connectivity in patients was attributed to compromised inter-
hemispheric structural connectivity, possibly caused by damage to the corpus callosum. 
Diffusion Tensor Imaging (DTI) data could have confirmed the structural damage 
hypothesis but unfortunately was not collected on that occasion. Nevertheless, several 
published reports detail damage to the corpus callosum following TBI [e.g. 9,10,11]. 
Interhemispheric transfer, thought to be mediated by corpus callosum white matter, is 
also widely discussed in the ever-expanding ageing literature in relation to maintenance 
of cognitive function and compensatory cross hemispheric activity [12,13], as well as in 
the context of motor recovery following stroke [14,15]. 
Although there is some evidence that motor recovery in patients with TBI stabilises 
clinically at six months to a year after injury [6], there is increasing evidence to suggest 
long-term progression of pathology. For example, Ramlackhansingh et al., 2011 [16] 
reported chronic inflammatory response following TBI and Potts et al., 2009 [17] 
showed that the injury can evolve up to two years post-insult, highlighting the need to 
consider TBI as a disease that evolves over time. Yet, later-stage TBI motor control 
functionality is rarely studied and, to our knowledge, there are no studies using the 
combination of techniques employed here to elucidate the degree of functionality in 
relation to structural integrity in patients with TBI. 
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To fully understand TBI progression, it is important to characterise later-stage 
functionally of brain networks such as the MCN using state-of-the-art technology (e.g. 
high resolution MRI) combined with appropriate analyses methods. The use of structural 
and functional connectivity data in addition to activation analyses allows for increased 
sensitivity in the characterisation of the MCN, since motor tasks involve widespread 
specialised areas whose modulation is mediated by functional demands [18].  
Methylphenidate has proven efficacy in the treatment of attention deficit hyperactivity 
disorder (ADHD) [19].  Patients with TBI often present with similar symptoms to patients 
with ADHD, and suffer from disrupted attention, compromised concentration and 
memory problems. Limited evidence also exists of the drug’s ability to modulate motor 
output in TBI [20] and to promote motor recovery in subcortical stroke [21]. Given our 
previous study demonstrating abnormalities of the MCN in TBI, and the modulatory 
effect of methylphenidate on neural activation and motor function in other settings, we 
undertook a proof of principle study to determine whether a single dose of the drug 
could improve MCN function following TBI. 
The research questions that we attempted to answer using fMRI and DTI data were 
whether a) patients with TBI have intact structural and functional MCNs and b) whether 
MCN functional enhancement is possible with a single dose of methylphenidate. We 
hypothesized, that following methylphenidate administration, activation and functional 
connectivity patterns in the TBI group would approach those of healthy controls. 
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2. Materials and Methods  
2.1. Study 
Two experimental groups, healthy controls and patients with later-stage (>6 months 
after the injury) TBI, participated in an early phase double-blind, placebo-controlled 
neuroimaging study, which aimed to provide a basis for selecting more targeted 
neurocognitive enhancers to treat TBI sequelae. Patients were tested overall for 
decreased attention span (rapid visual information processing task, [22]), working 
memory problems (n-back [23]), response inhibition (stop signal [24]), planning (tower of 
London [25]) and movement control. Our results for the working memory and the 
response inhibition tasks have been published by Manktelow et al., 2017 [26] and 
Moreno-Lopez et al., 2017 [27] respectively. This manuscript focuses on the MCN and 
the impact of methylphenidate on the motor network.  
All volunteers underwent MRI imaging (both structural and functional) on a Siemens 
Trio 3-Tesla-MR system at the Wolfson Brain Imaging Centre, at the University of 
Cambridge. A computer-generated table was used to randomise initial drug or placebo 
administration in the patient group. Patients were randomly allocated to be scanned on 
two separate occasions, 75 minutes after oral administration of either methylphenidate 
(30 mg) or placebo, in counterbalanced order. 30 mg of methylphenidate was used to 
ensure an effective dose was given, without increasing the likelihood of side effects.  
There is evidence of a dose-dependent response to the drug [19] with higher doses 
found to be more efficacious. Healthy controls were scanned twice without 
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pharmacological intervention. The average scan interval for both patients and controls 
was 2 weeks. 
2.2. Standard protocol approvals, registrations and patient consents 
The Cambridgeshire Research Ethics Committee approved the study, which was 
conducted according to Good Clinical Practice Guidelines, Declaration of Helsinki and 
the United Kingdom Central Council Code of Conduct. All volunteers provided informed 
written consent to participate in the study once experimental procedures had been 
explained. 
2.3. Participants 
Study participants (both healthy controls and patients) were between 19 and 58 years 
old and right-handed (handedness was self-reported). Healthy controls were recruited 
using advertisements around the Addenbrooke’s Hospital site in Cambridge. Patients 
had sustained TBI and been treated on the Neurosciences Critical Care Unit at the 
hospital. Eighteen patients and 20 healthy controls met the study criteria. However, two 
of the patients were unable to complete the scanning protocol because they did not 
tolerate the scanning process. Data from a further two patients were prospectively 
excluded because of excessive movement during the MRI scan. Six healthy controls 
were prospectively excluded to achieve evenly age-matched groups. Participants were 
individually age-matched and mean group differences in age were examined using a 
two-sample t-test (HC 37.43 + 12.89 vs. patients 37.49 + 14.07; p=0.99). Two 
experimental groups formed an age-matched sample, composed of 14 healthy controls 
and 14 patients. The mean duration from injury to first scan was 23 months. 
 
 
8 
 
Patient injury severity was classified using the Glasgow Coma Scale (GCS), as it is still 
the most commonly used score for classification of TBI severity in large trauma 
registries worldwide [28], due to its ease of use and low intra- and inter-rater variability. 
Our research database records the best available initial GCS.  By preference, if the 
post-resuscitation GCS is available, this is used.  However, several patients undergo 
tracheal intubation at the scene of accident because of airway or cardiorespiratory 
compromise and cannot have a GCS measured after hospital arrival.  In such patients, 
the initial GCS recorded at the scene of injury was used.  
Twelve participants from the TBI sample had a moderate or severe injury, as defined by 
the GCS at the scene of injury (severe defined as 8 or below and moderate as 9-12). 
One patient was injured abroad and required intensive care support for five days 
followed by a further three weeks of hospitalisation.  The acute CT scan report showed 
an intra-cerebral haemorrhage, temporal contusions and skull fractures.  Based on this 
medical history (without an initial GCS score available), the patient was determined to 
have had a severe injury.  Two patients had mild injuries with positive CT findings. 
Table 1 shows demographics and acute scan results for the TBI participants.  
Exclusion criteria for the study included the National Adult Reading Test <70, Mini 
Mental State Exam <23, left-handedness, history of psychiatric or neurological 
disorders, contraindications for MRI scanning, taking medication that could affect 
physical or cognitive performance (including tricyclic antidepressants and 
benzodiazepines), history of drug or alcohol abuse, or women in whom pregnancy had 
not been excluded (by pregnancy test where required). Further exclusion criteria were 
marked anxiety, agitation or tension, motor tics or siblings with tics, family history or 
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diagnosis of Tourette’s syndrome, hyperthyroidism, severe angina, cardiac arrhythmias, 
severe hypertension, heart failure, glaucoma, thyrotoxicosis, or epilepsy. 
In addition, patients were excluded if they had a physical disability that could prevent 
them from completing the tasks either in the screening or scanning stages, known 
sensitivity to methylphenidate, if they lived alone, or if they had been recruited into more 
than three research studies, or any other interventional study within a calendar year. 
***Table 1 is at the end of the manuscript*** 
 
2.4. Motor speed assessment 
To assess speed of motor response inside the scanner, we used reaction time data 
from the baseline condition of the Rapid Visual Information Processing (RVIP) task. 
RVIP measures sustained attention by asking participants to identify sequences of three 
numbers amongst pseudo-randomly presented single digits [29]. The baseline condition 
required participants to press their response button when they saw the digit 0 on the 
screen. This simple reaction time condition was used as an indication of motor speed in 
the scanning environment for both the healthy controls and the patient group. For the 
patients, this assessment provided reaction time measurements following the 
administration of methylphenidate or placebo.  
2.5. The fMRI motor paradigm 
The task utilised a block design involving a 30 second self-paced, repeated sequential 
finger opposition between thumb and digits 2 to 5 with the right hand during the move 
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epochs. Rest epochs lasting for 30 seconds followed movement epochs. Move and rest 
epochs were repeated five times and were visually cued by words (move or rest) 
appearing on a screen in the scanner. Participants were briefed on the task before 
entering the scanner. During the collection of the fMRI data all participants were visually 
observed to ascertain they were engaging with the task. 
2.6. MRI Imaging  
2.6.1. Structural and functional MR image acquisition  
After localiser scans, structural T1 scans were acquired to provide anatomical 
information and to aid spatial normalisation to Montreal Neurological Institute (MNI) 
space. Acquisition parameters were as follows: repetition time 2300 milliseconds (ms), 
echo time 2.98ms, flip angle 90, field of view 256mm2 x 256mm2.   
A resting state fMRI scan was collected after the structural scan and this was followed 
by the motor task fMRI data collection. An EPI sequence was utilised to acquire 
continuous functional images with the following parameters: repetition time 2000 ms, 
echo time 30ms, flip angle 780, field of view 192mm2 x 192mm2, 32 slices 3.00mm thick 
with a gap of 0.75mm between slices. 
DTI data (63 non-collinear directions, b = 1000 s/mm2 with one volume acquired without 
diffusion weighting (b = 0), echo time 106 ms, repetition time 1700ms, field of view 192 
mm×92 mm, 2 mm3 isotropic voxels) were also collected to investigate white matter 
integrity. 
2.6.2. Preprocessing and analysis of DTI data 
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The DTI data were eddy current corrected and realigned using FSL 
(fsl.fmrib.ox.ac.uk/fsl). Fractional anisotropy (FA) images were calculated and spatially 
normalised by constructing a study specific template as discussed previously by our 
group [30]. The spatially normalised images were smoothed with an 8 mm isotropic 
Gaussian filter. A voxel-wise fractional anisotropy comparison between healthy controls 
and patients with TBI was carried out using a two-sample t-test in SPM8. Further, we 
used reaction time data obtained in the scanner, in a whole brain linear regression 
analysis to evaluate whether motor speed related to alterations in FA.  
Results were considered significant if they reached a p-value of 0.001 uncorrected at 
the voxel level, and a cluster p-value of <0.05 FWE corrected for multiple comparisons 
for a whole brain white matter mask. Significant alterations in fractional anisotropy were 
further examined with MRIcroN software 
(http://www.mccauslandcenter.sc.edu/mricro/mricron) utilizing the JHU-white matter 
atlas to annotate significant clusters. 
2.6.3. Preprocessing and analysis of fMRI data 
Functional MRI data were preprocessed and analysed using SPM8 
(www.fil.ion.ucl.ac.uk/spm/) within Matlab (www.mathworks.co.uk/products/matlab). 
The first five images of each fMRI scanning session were discarded to allow for MR 
signal stabilisation. After slice-timing correction and realignment, the T1 structural scan 
for each volunteer was coregistered with their mean EPI image. The coregistered 
structural scans were then segmented and the grey matter probabilistic images were 
spatially normalised to a grey matter template (Montreal Neurological Institute; MNI; 
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(http://www.mcgill.ca/neuro/). The normalisation parameters obtained from this process 
were applied to the realigned fMRI images, in effect bringing them to MNI space. 
Smoothing with an 8mm Gaussian kernel was the final preprocessing step. All images 
were visually inspected after preprocessing to ensure correct spatial normalisation.  
Statistical modelling utilised the General Linear Model (GLM) framework. Move and rest 
onsets (and durations) convolved with the canonical haemodynamic response function 
were used as regressors of interest at the single subject level.  
The healthy control motor control network, as established from the subtractive analysis 
above, informed whole brain voxel-wise Psychophysiological Interaction (PPI) analyses, 
carried out to investigate functional connectivity changes with methlyphenidate. The PPI 
framework allows the extraction of task specific time series and is used to examine how 
activity in one brain area relates to activity in another brain area in the context of a 
specific task [31]. The subject level GLM for the PPI models included a task specific 
time-series for the area of interest as well as 6 movement parameters as confounds. 
Seeds for the PPI analyses included the left primary motor cortex, the left primary 
somatosensory cortex, the right cerebellum, the right lateral premotor cortex, the left 
thalamus, right primary somatosensory cortex and left cerebellum.  
Group random-effects analyses for both activation and connectivity analyses were 
carried out using one-sample, two-sample and paired t-tests to assess group effects 
and differences. Group level neuroimaging statistics utilised a combination of voxel- and 
cluster-level thresholds and results were considered significant when they reached a p-
value of 0.001 uncorrected at the voxel level, and a cluster p-value of <0.05 corrected 
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for multiple comparisons for the entire brain (Family-Wise Error correction, FWE). The 
peak significant co-ordinates from all neuroimaging analyses were annotated using 
MRIcroN software (http://www.mccauslandcenter.sc.edu/mricro/mricron) and the 
automatic anatomical labelling (AAL) atlas [32] as well as Bradmann area templates.  
 
3. Results  
3.1. Behavioural data 
Reaction time data confirmed that healthy controls were significantly faster than patients 
on placebo (426.97 + 50.6 vs. 481.57 + 68.44 ms, respectively; p= 0.02, Figure 1). The 
reaction time comparison between healthy controls and patients on methylphenidate did 
not produce a significant result (440.75 ms + 60.65; p= 0.52, Figure 1). Further, within-
patient group comparison revealed that patient reaction time was significantly faster on 
methylphenidate than it was on placebo (p=0.005, Figure 1). 
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Figure 1: Comparison of reaction times (ms) between healthy controls and patients. 
Patients were assessed twice on methylphenidate and placebo. 
 
3.2. Imaging analysis  
3.2.1. White matter integrity in the patient group 
Near global changes in fractional anisotropy and therefore white matter alteration was 
seen in the patients when compared to the control group. Patients with TBI had reduced 
fractional anisotropy in the areas highlighted in Figure 2A. Such widespread changes 
are expected to have an effect in motor function and in order to test this hypothesis we 
assessed whether the speed of response after placebo administration was related to 
reductions in FA. The whole brain multiple linear regression analysis revealed several 
significant clusters (see Table 2 and Figure 2B for statistical peaks). FA in bilateral 
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cerebellar white matter bundles (L & R middle, superior and inferior cerebellar 
peduncles) as well as left lateralised white matter bundles (L external capsule, L 
anterior limb of internal capsule, L posterior limb of internal capsule, L genu of corpus 
callosum, L cingulum, L posterior corona radiata, L superior longitudinal fasciculus) and 
R posterior thalamic radiation, negatively correlated with reaction times. Lower FA in 
motor-function-relevant white matter bundles was thus associated with longer reaction 
times. The cerebellar peduncles, corona radiata/internal capsule, and corpus callosum, 
have all been implicated in motor function [33].  
***Table 2 is at the end of the manuscript*** 
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Figure 2: [A] Widespread FA reductions in patients with TBI compared to healthy 
controls. 3D reconstructions demonstrate the widespread extent of changes while 
orthogonal z slices provide more specific anatomical information. Numbers represent 
MNI z-axes coordinates. [B] The speed of response for the patients related to 
reductions in FA in several left lateralised white matter bundles including the left coronal 
radiate. However, left lateralisation does not persist in the cerebellum where we found 
bilateral cerebellar peduncles to be related to reaction times. 
 
3.2.2. Activation results 
During the sequential finger-thumb opposition task, healthy controls activated a network 
comprising left cerebellum, right lateral premotor region and right 
supramarginal/somatosensory cortex in addition to areas commonly implicated in motor 
control function such as left precentral/primary motor cortex (LpreC), left 
postcentral/primary somatosensory cortex (LpostC) and right cerebellum. After placebo 
administration, the patients activated a left lateralised (except cerebellum) aspect of the 
MCN. This comprised a subset of the areas activated in the healthy controls, namely the 
left primary motor cortex, left primary somatosensory cortex, right cerebellum, left 
supplementary motor area and left thalamus. Following methylphenidate administration, 
the patients showed additional activations in the right lateral premotor area, and right 
supramarginal cortex (Figure 3A, Table 3).  
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Patient group comparison (placebo/methylphenidate) revealed a statistically significant 
cluster in the left inferior frontal gyrus (Figure 3B, Table 4), which activated significantly 
more when patients were on methylphenidate.  
***Table 3 is at the end of the manuscript*** 
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Figure 3: [A]: MCN activation in healthy controls and patients with placebo and 
methylphenidate [B]: Differences in activation between drug and placebo in patients with 
TBI. [C]: Significant differences in functional connectivity (PPI) in patients with TBI on 
drug versus placebo from right premotor cortex (top) and left postcentral cortex. Inflated 
brains were constructed using CARET 
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 (http://brainvis.wustl.edu/wiki/index.php/Caret:Download) 
***Table 4 is at the end of the manuscript*** 
 
3.2.3. Functional connectivity - Whole brain, seed-based connectivity analysis  
Following methylphenidate administration, the patients demonstrated functional 
connectivity over and above that on placebo, specifically between the right lateral 
premotor seed and a) the parietal lobe bilaterally and b) the left middle frontal gyrus 
(Figure 3C). Additionally, when on methylphenidate, the left postcentral cortex 
significantly increased its functional connectivity with cerebellar areas including the 
vermis (Figure 3C).  
In summary, the whole-brain functional connectivity analyses concurred with the 
structural connectivity data which suggested a compromised MCN following TBI. Over 
and above this, the functional connectivity data showed stronger MCN connectivity on 
methylphenidate; a finding that may signify enhanced residual functionality of the MCN 
network when performing right handed sequential movement. Significantly faster 
reaction times on methylphenidate also suggest MCN enhancement. 
 
4. Discussion  
4.1. Reaction time data in healthy controls versus patients 
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The behavioural data we collected and analysed in this study suggested that the healthy 
control group produced more efficient, faster, motor outputs in keeping with previous 
findings, which also suggest that, despite apparently good motor recovery, patients with 
later-stage TBI present with a slowing in motor performance [34]. The reaction time 
findings in our study were supported by both DTI findings and functional activation/ 
connectivity results. This slowness in motor function in patients with TBI was 
ameliorated by methylphenidate. Patients were significantly faster on methylphenidate 
than on placebo, and not significantly different from healthy controls when they took 
methylphenidate.  
4.2. MCN activation in patients with later-stage TBI 
Healthy controls activated an MCN which included the left primary motor cortex, the left 
primary somatosensory cortex, the right cerebellum, the right lateral premotor cortex, 
the left thalamus, right primary somatosensory cortex and left cerebellum. Patients on 
placebo presented with a subset of the activations we noted in the control group.  
Methylphenidate administration resulted in an augmented MCN activation, which partly 
restored the network to control activation levels. 
Comparison between patients on methylphenidate and placebo revealed a significant 
difference in activation in the left inferior frontal cortex. Haggard, 2008 [35] described a 
frontal cognitive aspect of the motor network, in which the more anterior prefrontal 
structures are involved in prior action intention. Furthermore, intact interactions between 
frontal and subcortical areas (basal ganglia and the thalamus) are key when 
behavioural flexibility and cognitive control over actions is required [7]. Our TBI group 
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showed widespread structural disconnections, including those between frontal and 
subcortical areas as demonstrated by our DTI analysis. These compromised 
connections may be influencing the reconfiguration and updating of action plans [7]. It is 
also possible that the additional inferior frontal activation found in this study when 
patients were on methylphenidate, reflected augmented residual fronto-subcortical 
interactions, resulting in shorter reaction times. 
4.3. Functional MCN connectivity in patients with later-stage TBI on 
methylphenidate 
Both our functional and structural connectivity data support the presence of a 
compromised MCN following TBI. A likely explanation is that white matter structural 
changes, as evidenced by the DTI data, are causing the changes in functional 
connectivity we observed during the sequential finger opposition task. Such 
abnormalities in structural connectivity have been widely reported after TBI 
[9,36,37,17,11].  
Functional connectivity between the right lateral premotor cortex and parietal cortices 
was augmented by methylphenidate, suggesting enhanced neural processing to support 
movement output. The lateral premotor cortex plays an important role in the 
transformation of sensory information into appropriate motor behaviour, with the right 
lateral premotor area being linked to the performance of motor sequences [38]. It has 
also been suggested that the lateral premotor areas support other brain regions to 
integrate information for response and timing of action and possibly to generate the final 
movement selection for both internal and external actions [39,40]. These findings further 
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support Frey et al.’s, 2011 [2] proposal that the lateral premotor area is important for 
action selection, serving as the interface between the prefrontal and parietal association 
cortices for the primary motor cortex [2].   
Furthermore, Zimmerman et al., 2012 [41] found that motor tasks requiring attention 
switching involve the frontal and parietal lobes, as part of a supramodal frontoparietal 
attentional network, especially in the right cortical hemisphere, which has been 
implicated with cortical inhibition in motor tasks. Hence, these structures are overall 
involved with sensory processing and associative, cognitive processes [38,42,2].  
Following methylphenidate administration another cluster which displayed increased 
connectivity to the right lateral premotor cortex was found in left lateral premotor 
cortex/left middle frontal gyrus. When task uncertainty is increased, either for response 
selection or timing, the lateral premotor area has been found to respond bilaterally in 
healthy controls [39]. Additionally, the left middle frontal gyrus has been linked to 
attention in motor tasks although this has been more commonly observed in the context 
of self-initiated rather than cued movements [38]. Overall, the interaction between the 
sensory processing and associative regions with lateral premotor cortices may signify 
information transformation/integration from sensory cortices to produce movement 
[39,42,38,2,40,43].  
Increased functional connectivity under methylphenidate was also observed between 
the left postcentral cortex and the cerebellum. This again highlights the importance of 
sensory processing to augment motor production as the postcentral cortex is the 
primary somatosensory cortex with documented links to subcortical structures. 
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Increased connectivity of this area to the cerebellum, may influence the timing and 
correct activation of muscles [2]. The importance of sensory input to driving motor 
output should not be overlooked and further research in this area may benefit from the 
use of sensory testing to establish the level of intact sensory information available to 
patients.  Rothwell et al., 1982 [44] suggested that without sensory information 
movement can become clumsy. Evidence from other studies also highlights the 
importance of tactile and proprioceptive information for movement production 
[45,39,46]. During movement, sensory information is integrated into motor processing to 
adjust performance in relation to environmental demands [41]; it remains however 
unclear how the salience of sensory input is defined within the motor processing 
pathway [3]. 
Motor control in patients with later-stage TBI is not widely studied, and to our 
knowledge, there are no studies using data directly comparable to ours. Our previous 
study reviewed psychophysiological interactions in the MCN [8], using a simpler finger-
to-thumb opposition task. Sequential movements used here, have been found to 
activate additional areas to those required in less complex movements [47,48,46,38]. 
Data from the current study complements our earlier findings which suggested 
compromised functional connectivity in the MCN in patients with later-stage TBI, but 
elucidating causality in these interactions will require additional studies.  
4.4. Methylphenidate and enhancement of the MCN under the drug condition 
Patients on methylphenidate displayed enhanced activations in the left hemisphere and 
greater functional connectivity. Methylphenidate is thought to increase synaptic 
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dopamine [49] and such increases may have resulted in enhanced cortico-striatal loops 
that modulate motor function [50]. The results in our study suggest that methylphenidate 
may have augmented motor output in agreement with an earlier study on subcortical 
stroke [21] where methylphenidate was shown to enhance finger movement. In the 
subcortical stroke sample, the methylphenidate-induced improvement in motor 
performance was accompanied by task related cortical activation in the ipsilesional 
primary sensorimotor cortex and the contralesional, premotor cortex (Tardy et al., 2006). 
This line of evidence supports the hypothesis that the connectivity patterns we observed 
with a single dose of methylphenidate could reflect a facilitated, more extensive MCN 
network which compensates for loss of neural resources within the baseline MCN we 
observed being recruited on placebo. 
Compensatory increases in cortical activation following TBI have been recognised is an 
important driver of motor recovery [51]. While not addressed by our experiment, 
enhancement of dopaminergic neurotransmission has also been shown to improve 
post-training retention of a motor task [50], altogether suggesting that methylphenidate 
may improve not just motor performance, but also motor learning.   
4.5. Limitations of study 
The main limitation of this study was that the patients we recruited were not screened 
with extensive motor or sensory assessments. Patients were considered clinically to 
have ‘good’ motor outcomes, yet we found alterations in structural and functional 
connectivity in their MCN. Future studies should assess in detail whether any 
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motor/sensory deficits are present. Assessment should also include co-ordination and 
timing of movements as a way of evaluating subcortical functionality. 
Evaluation of tapping rate during scanning would allow for a more reliable assessment 
of motor output and differences that may exist between healthy controls and patients. 
Unfortunately MRI compatible hardware to collect tapping rate data was not available 
during this experiment. Data collected in this manner would provide a precise 
assessment of potential changes which may be due to alteration in the MCN of patients 
with later-stage TBI.   
Functional MRI studies, even among healthy controls, demonstrate a high level of 
variability for externally triggered finger movement paradigms [52,38]. In future studies, 
consideration should be given to the manner in which patient variability can be 
addressed, especially in a patient population recognised as highly heterogeneous [7]. It 
is possible that variables introduced during data analysis to stratify the subjects into 
‘higher’ or ‘lower’ movement groups will provide a fairer group evaluation. It is also 
important that consideration should be given to how patients with later-stage TBI are 
categorised by injury severity. It is possible that the use of a classification using 
symptoms, such as loss of consciousness period or length of post-traumatic amnesia, 
may be more appropriate [0]. 
Although comparable with previous studies, it would be important to replicate this study 
with a larger sample size. Specifically, future studies aiming to define the biological 
mechanisms of methylphenidate on neural networks following TBI should aim to recruit 
a larger cohort of patients with severe TBI. The heterogeneity of this particular cohort 
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makes it difficult to generalize findings but with a larger number of patients the statistical 
power would be improved resulting in more generalizable identification of the 
differences in motor outcomes within TBI groups. 
Finally, our study did not include patients with major motor control problems. The main 
reason for this is that other fMRI tasks utilised in this study (working memory, planning, 
sustained attention, response inhibition) required button pressing. The use of resting 
state fMRI in future studies will allow the assessment of the motor control network in 
patients with severe TBI without requiring a response in the scanner environment. 
4.6 Conclusions 
The MCN was not characterised extensively by this early phase study; however, this 
study revealed specific structural and functional connectivity changes in patients with 
later-stage TBI. MCN augmentation following the administration of methylphenidate in 
patients with TBI resulted in restoration of reaction times making them similar to those 
observed in healthy controls. The immediate effects of the drug suggest that the 
methylphenidate-induced modulation of the MCN that we observed could have 
application in physical rehabilitation in later-stage motor deficits following TBI by 
supporting residual connectivity.  
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Tables 
Table 1: Demographic data and acute CT scan results for TBI patients. SAH 
Subarachnoid haemorrhage; DAI Diffuse Axonal Injury; EDH Extradural haemorrhage; 
SDH Subdural hematoma. 
Time 
injury to 
scan 1 
(months) 
Age at 
scan 
Sex GSC on 
scene 
Scan results (acute) 
25 27 
years 5 
months 
M 7 Blood products surface both frontal 
lobes at grey/white matter interfaces 
and corpus callosm. No mass lesion 
18 55 
years 7 
months 
F 12 L SAH sulci,  frontoparietal convexity 
14 29 
years 1 
month 
M 5 Multiple haemorrhagic contusions L 
temporal lobe. Haemorrhage L basal 
ganglia. R thalamus. R subcortical 
diffuse axonal injury 
37 49 
years 9 
months 
F 5 Small foci L cerebral peduncle and 
superior frontal lobes 
32 19 
years 3 
months 
M 7 No abnormality. Subarachnoid blood 
10 58 
years 9 
months 
M 14 Haemorrhages orbital frontal cortex. 
Subarachnoid blood 
40 21 
years 6 
months 
M 5 Multiple petechial haemorrhages, 
basal cisterns obliterated, SAH, DAI. 
Small midline shift to L 
8 19 
years 4 
M 8 R frontoparietal extra-dural. Subdural 
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months haematoma. R parietal fracture 
27 49 
years 8 
months 
M 8 Haemorrhagic contusion L lentiform 
nucleus. Small focal lesion pons. 
Bilateral subcortical area frontal lobes. 
Signal change in corpus callosm 
11 36 
years 
11 
months 
M 6 R temporal EDH, haemorrhagic 
contusions anterior aspect L temporal 
lobe, posterior inferior R frontal lobe. 
Scattered areas traumatic SAH in 
interpeduncular fossa and some of the 
posterior convexity sulci of both 
hemispheres 
26 26 
years 
10 
months 
M 7 Intraventricular haemorrhage 
41 34 
years 5 
months 
F Unavailable Intra-cerebral haemorrhage. R 
temporal contusion 
6 43 
years 2 
months 
M 10 R SAH and SDH 
33 53 
years 2 
months 
M 14 R SAH and SDH. Haemorrhagic 
contusion R posterior temporal lobes. 
Multiple areas contusion superior 
frontal lobes and R cerebellar 
hemisphere, R temporal and inferior 
frontal lobes 
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Table 2: Significant peak voxels from the linear regression evaluating the relationship 
between FA and reaction times following placebo administration.  
 
 
 
 
 
 
 
 
 
 
 
p-
value 
Extent X y z t-score Peak in cluster 
0.006 2455 -18 -41 44 7.6 L posterior corona radiata 
0.000 6229 8 -58 -30 6.93 R Middle cerebellar peduncle 
0.010 2175 -48 -26 -20 6.6 L Sagittal stratum (include inferior 
longitudinal fasciculus and inferior 
fronto-occipital fasciculus) 
0.015 2002 -6 16 -7 6.41 L Genu of corpus callosum 
0.006 2466 -47 -32 36 6.14 L superior Longitudinal Fasciculus 
0.023 1798 -29 3 6 5.8 L external Capsule 
0.015 2009 -3 18 27 5.04 L Cingulum 
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Table 3: Significant peak voxel activations in the MCN in all experimental groups are 
reported for clusters surviving a voxel threshold of p< 0.001 uncorrected and cluster 
threshold of p< 0.05 FWE-corrected for multiple comparisons. 
 
Subject 
group 
p-value Extent X y z t-score BA Peak in cluster 
Controls  0.000 
 
5311 -40 
-36 
-48 
-30 
-24 
-22 
50 
64 
48 
17.76 
13.18 
11.79 
3 
4 
3 
L postcentral 
L precentral 
L postcentral 
 0.000 1845 22 
14 
6 
-52 
-50 
-62 
-24 
-20 
-18 
16.00 
15.24 
8.55 
 R cerebellum 
R cerebellum 
Vermis 
 0.000 411 58 
58 
10 
4 
18 
38 
13.08 
10.40 
6 
6 
R precentral 
R precentral 
 0.000 699 40 
28 
-12 
-12 
62 
56 
10.76 
8.66 
6 
6 
R precentral 
R precentral 
 0.000 741 
 
-22 
-18 
-54 
-68 
-26 
-22 
9.19 
6.48 
 L cerebellum 
L cerebellum 
 0.000 1063 -14 -20 2 9.03  L thalamus 
 0.000 1051 46 
64 
60 
-30 
-14 
-18 
42 
26 
20 
8.44 
7.83 
7.77 
2 
43 
48 
R supramarginal 
R supramarginal 
R supramarginal 
 0.013 205 12 
26 
6 
-66 
-54 
-68 
-46 
-42 
-36 
8.23 
4.74 
4.59 
 R cerebellum 
R cerebellum 
Vermis 
Placebo 0.000 2444 -38 
-38 
-46 
-24 
-20 
-26 
52 
62 
54 
13.16 
10.91 
10.54 
3 
4 
3 
L postcentral 
L precentral 
L postcentral 
 0.000 381 -6 
-10 
-4 
4 
56 
60 
11.26 
5.14 
6 
6 
L SMA 
L SMA 
 0.000 537 14 -52 -28 10.28  R cerebellum 
 0.000 297 -16 
-24 
-30 
-18 
-12 
-18 
6 
2 
0 
7.71 
6.49 
5.38 
 L thalamus 
L pallidum 
L putamen 
Drug 0.000 2919 -34 
-36 
-44 
-8 
-20 
-36 
54 
54 
46 
11.81 
11.47 
9.93 
6 
4 
2 
L precentral 
L precentral 
L inferior parietal 
 0.000 421 -14 
-28 
-20 
-14 
-22 
-6 
8 
4 
4 
11.06 
6.83 
6.61 
 L thalamus 
L putamen 
L pallidum 
 0.000 580 -6 -4 68 9.11 6 L SMA 
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-2 0 58 7.49 6 L SMA 
 0.000 747 6 
20 
14 
-48 
-56 
-60 
-10 
-18 
-14 
9.94 
6.77 
6.33 
 Vermis 
R cerebellum 
R cerebellum 
 0.000 309 26 
40 
-6 
-6 
66 
62 
8.51 
6.30 
6 
6 
R superior frontal 
R prefrontal 
 0.003 191 38 
40 
-34 
-40 
40 
46 
6.18 
4.89 
40 
40 
R supramarginal 
R inferior parietal 
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Table 4: Significant peak voxel activations for the difference between patients on 
methylphenidate and patients on placebo. 
 
Contrast p-
value 
Extent X y z t-
score 
BA Peak in cluster 
 Drug-
Placebo 
0.000 
 
311 -54 
-54 
-50 
20 
28 
24 
20 
10 
-6 
4.43 
3.29 
3.27 
48 
45 
38 
L Inferior triangularis 
L Inferior triangularis 
L Inferior orbitalis 
 
 
 
